T cell-eosinophil crosstalk-A new road for effective immune checkpoint blockade in breast cancer?
- PMID: 36525972
- DOI: 10.1016/j.ccell.2022.11.008
T cell-eosinophil crosstalk-A new road for effective immune checkpoint blockade in breast cancer?
Abstract
Immune checkpoint blockade (ICB) has revolutionized the landscape of cancer treatment. Nevertheless, most cancer patients still do not respond to ICB. In this issue of Cancer Cell, Blomberg et al. illustrate a critical cooperation between T cells and eosinophils, which jointly enhance effectiveness of ICB in breast cancer.
Copyright © 2022 Elsevier Inc. All rights reserved.
Comment on
-
IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer.Cancer Cell. 2023 Jan 9;41(1):106-123.e10. doi: 10.1016/j.ccell.2022.11.014. Epub 2022 Dec 15. Cancer Cell. 2023. PMID: 36525971
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
